Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syncytial Virus Respiratory Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02618213
What this trial is testing

Comparison of High Flow Oxygenation Therapy and CPAP in Children With Bronchiolitis.

Who this might be right for
Respiratory Syncytial Virus Bronchiolitis
Esbjerg Hospital - University Hospital of Southern Denmark 50
Testing effectiveness (Phase 2)Study completedNCT03691623
What this trial is testing

A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 179
Testing effectiveness (Phase 2)Study completedNCT02718937
What this trial is testing

Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study

Who this might be right for
Respiratory Syncytial Virus (RSV) Infection
Biota Pharma Europe Limited 60
Not applicableEnded earlyNCT03909867
What this trial is testing

Emission Patterns of Respiratory Syncytial Virus

Who this might be right for
RSV InfectionAerosol Disease
Wake Forest University Health Sciences 7
Not applicableStudy completedNCT01349543
What this trial is testing

The Development of a Human Model of Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Virus InfectionsRespiratory Viral Infections
Imperial College London 58
Large-scale testing (Phase 3)WithdrawnNCT05229068
What this trial is testing

Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Female Participants of 18-49 Years of Age During Their Subsequent Uncomplicated Pregnancy

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline
Early research (Phase 1)Study completedNCT01355016
What this trial is testing

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers

Who this might be right for
Drug SafetyRespiratory Syncytial Virus Infections
MicroDose Therapeutx, Inc 48
Large-scale testing (Phase 3)Study completedNCT05590403
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adults 60 Years of Age and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,544
Not applicableStudy completedNCT02622009
What this trial is testing

Viral Infections in BAL and Bronchial Biopsies of Stable COPD Patients

Who this might be right for
HRV and RSV Presence in the Lungs of Stable COPD Patients.
University of Athens 53
Early research (Phase 1)Study completedNCT03750383
What this trial is testing

Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 48
Not applicableUnknownNCT01684527
What this trial is testing

Immature Myeloid Cells in Respiratory Syncytial Virus Bronchioliltis

Who this might be right for
Bronchiolitis
Hillel Yaffe Medical Center 55
Not applicableStudy completedNCT03095495
What this trial is testing

High Flow Nasal Cannula Therapy in Bronchiolitis : Early vs Rescue

Who this might be right for
BronchiolitisRespiratory Syncytial Virus (RSV)
Hamad Medical Corporation 28
Early research (Phase 1)Active Not RecruitingNCT06216093
What this trial is testing

Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years

Who this might be right for
Respiratory Syncytial Virus InfectionsRespiratory Syncytial Virus (RSV)
EuBiologics Co.,Ltd 100
Not applicableUnknownNCT06392451
What this trial is testing

LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia

Who this might be right for
Influenza AInfluenza Type BCoronavirus Disease 2019+8 more
DiaSorin Molecular LLC 1,000
Not applicableUnknownNCT05618769
What this trial is testing

Towards Life-Long Healthy Lungs: A Multidisciplinary Follow-up Framework for Preterm Infants

Who this might be right for
Premature BirthRespiratory DiseaseRespiratory Tract Infections+11 more
Franciscus Gasthuis 330
Testing effectiveness (Phase 2)Study completedNCT03636906
What this trial is testing

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 201
Not applicableStudy completedNCT05164692
What this trial is testing

Effects of Nasal-spraying LiveSpo Navax in Treatment of Acute Respiratory Infections in Children

Who this might be right for
Acute Respiratory Tract Infections
National Children's Hospital, Vietnam 100
Not applicableStudy completedNCT03574532
What this trial is testing

Determine the Epidemiology and Evaluate the Burden of Disease in Respiratory Syncytial Virus/Human Metapneumovirus and Influenza A Infected Hospitalized Participants (Adults and Children)

Who this might be right for
Respiratory Tract Infections
Janssen-Cilag International NV 118
Large-scale testing (Phase 3)Study completedNCT03171142
What this trial is testing

Effect of Heliox on RSV Bronchiolitis

Who this might be right for
RSV InfectionAcute Bronchiolitis
Wael Seliem 104
Testing effectiveness (Phase 2)Study completedNCT03524118
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)

Who this might be right for
Respiratory Tract InfectionRespiratory Syncytial Virus
Merck Sharp & Dohme LLC 183
Next Page